This activity is supported by an independent education grant from Lilly. This online education program has been designed for healthcare professionals globally.

Join leading experts Dr Anton Porsteinsson, MD, Dr Petrice Cogswell, MD, PhD, Dr Korilyn Zachrison, MD, MSc and Dr Chuck Vega, MD for this accredited virtual live session. Utilizing immersive, narrative-style clinical cases and decision-point audience polling, this expert-led session equips healthcare providers with the tactical, evidence-based strategies needed to confidently coordinate ARIA care, reduce diagnostic variability in imaging interpretation, and proactively manage treatment risks through multidisciplinary collaboration across the patient pathway.

Participants will gain actionable strategies for leading individualized shared decision-making conversations, navigating complex ARIA re-initiation and dose modifications, and implementing the coordinated, multidisciplinary escalation protocols essential for preventing acute mismanagement and maximizing patient safety across care settings.

Credits: 1 AMA PRA Category 1 Credits™ (0.75.00 hours)

Session Highlights

• Leading Individualized Shared Decision-Making (SDM) Conversations: Focuses on equipping primary care and nursing professionals with practical tools to communicate treatment trade-offs, navigate patient hesitation surrounding ARIA-related side effects, and effectively align care choices with individual patient values and goals.
• Reducing Diagnostic Variability in ARIA Imaging Interpretation: Designed for radiology and neuroradiology teams to align interpretations across different modalities—such as resolving uncertainty when microhemorrhages appear on susceptibility-weighted imaging (SWI) but not clearly on gradient recalled echo (GRE)—to eliminate diagnostic inconsistency.
• Restoring Confidence in ARIA Re-Initiation and Dose Modification: Explores neurology- and psychiatry-focused, AUR-informed strategies to guide clinicians through safe treatment restarts, precise dose adjustments, and longitudinal monitoring after therapy has been paused for ARIA resolution.
• Preventing Acute Mismanagement Through Coordinated Escalation: Outlines critical multidisciplinary protocols spanning the Emergency Department, radiology, and neurology to ensure patients presenting with ARIA symptoms are accurately triaged and not mismanaged as acute stroke cases.

Who Should Watch

This program is designed for healthcare professionals involved in Alzheimer’s disease diagnosis, imaging, treatment, and acute evaluation, including:

• Neurologists
• Radiologists
• Neuroradiologists
• Emergency medicine physicians
• Psychiatrists
• Geriatric psychiatrists
• Primary care physicians (MD/DO)
• Nurse practitioners
• Physician assistants
• Infusion center staff
• Nursing staff
• Triage specialists

Faculty

Anton Porsteinsson, MD, is the Director of the University of Rochester Alzheimer's Disease Care, Research and Education Program (AD-CARE) and the William B. and Sheila Konar Professor of Psychiatry at the University of Rochester School of Medicine and Dentistry. Board-certified in Psychiatry with specialized qualifications in Geriatric Psychiatry, he is an internationally recognized authority on Alzheimer's disease, dementia, and memory disorders. Dr. Porsteinsson's distinguished career focuses on clinical trials, biomarkers, neuroimaging, and novel pharmacologic therapies aimed at addressing both cognitive loss and behavioral disturbances. As a leading investigator for prominent national prevention and treatment trials and the author of hundreds of research publications, he brings profound expertise to this session on navigating complex treatment decisions and coordinating multidisciplinary care across the patient pathway.

Petrice M. Cogswell, MD, PhD, is an Associate Professor of Radiology and Consultant in the Division of Neuroradiology at Mayo Clinic, Rochester. A leading expert in advanced neuroimaging, her research focuses on the intersection of quantitative MRI, machine learning, and biomarker modeling to enhance the diagnosis of neurodegenerative disorders. Dr. Cogswell is a prominent figure in the field of Alzheimer’s disease, currently serving as Vice Chair of the ARIA and Dementia Study Group for the American Society of Neuroradiology and as a member of the AHA Amyloid-Related Imaging Abnormalities Summit Planning Committee. Her work is instrumental in developing the imaging protocols and clinical workflows used to detect and monitor ARIA in patients receiving anti-amyloid immunotherapies. Dr. Cogswell also serves as a Co-Investigator for several NIH-funded initiatives, including the Alzheimer’s Clinical Trials Consortium (ACTC) and the Alzheimer’s Disease Neuroimaging Initiative (ADNI), dedicated to advancing safe, personalized care through innovative imaging science.

Kori S. Zachrison, MD, MSc, is an Associate Professor of Emergency Medicine at Massachusetts General Hospital and Harvard Medical School. An expert in optimizing systems for time-sensitive emergency care delivery, her academic and clinical focus centers heavily on telemedicine and stroke systems of care. Dr. Zachrison is continuously funded by major institutions including the National Institute of Neurological Disorders and Stroke (NINDS) and the American Heart Association (AHA), and she co-leads a national stroke quality improvement initiative through the American College of Emergency Physicians Emergency Quality Network (E-QUAL). Her deep expertise in emergency medicine and stroke care delivery provides critical, cross-functional insights into this session’s focus on navigating emergency department triage and ensuring coordinated multidisciplinary escalation across the patient pathway.

Chuck Vega, MD, is a Health Sciences Clinical Professor of Family Medicine, Associate Dean, and the Executive Director of the Program in Medical Education for the Latino Community (PRIME-LC) at the University of California, Irvine School of Medicine. He earned his undergraduate degree from Harvard University and his medical degree from the University of Wisconsin–Madison before completing his Family Medicine residency training at UC Irvine. For over two decades, Dr. Vega has dedicated his clinical practice to providing compassionate care to underserved populations and training the next generation of physicians at UC Irvine’s Family Health Center–Santa Ana, the largest safety-net clinic in Orange County. An award-winning educator and Macy Faculty Scholar, his academic focus centers on eliminating health disparities and designing innovative training programs for community health.

Disclosures

Partners for Advancing Clinical Education (Partners) requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships are mitigated according to Partners policies.

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (Partners) and MedAll. Partners is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Education

Partners designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1 ANCC contact hours.

Pharmacy Continuing Education

Partners designates this continuing education activity for TBC contact hour(s) (0.TBC CEUs) of the Accreditation Council for Pharmacy Education.

(Universal Activity Number - xxxxxxx-xxx-xx-xxx-xxx)

Type of Activity (select one): Knowledge or Application

Fee Information

There is no fee for this educational activity.